about
Acute hepatitis C: prevention and treatmentClinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionUpdate on hepatitis C: Direct-acting antiviralsSocio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional surveyEnhancing our understanding of current therapies for hepatitis C virus (HCV)Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary studyDiagnosis, management, and treatment of hepatitis C: an updateChanges of shear-wave velocity by interferon-based therapy in chronic hepatitis C.Elderly recipients of hepatitis C positive renal allografts can quickly develop liver diseaseTreatment of hepatitis C. The 2002 French consensus.Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.Liver enzyme alteration: a guide for clinicians.Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control studyNested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypesTriple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.A review on laboratory liver function tests.Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis CDevelopments in the treatment of chronic hepatitis C.HIV co-infection accelerates decay of humoral responses in spontaneous resolvers of HCV infection.Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.Fibrosis and disease progression in hepatitis C.Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infectionWorsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.Quality of life in hepatitis C.Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineWhat is the real function of the liver 'function' tests?An analysis of risk factors for developing Hepatocellular carcinoma in a group of Hepatitis C patients with stage 3 fibrosis following interferon therapy.Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C.In the clinic. Hepatitis C.Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response.Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting.Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells.Host genetic basis for hepatitis C virus clearance: a role for blood collection centersTreatment of acute HCV infection.
P2860
Q22305934-194777FC-7A31-4FF4-972D-146312F9474CQ24791398-347EE8F1-9D4E-42D4-A754-3942FA57C631Q26746563-8C1C4421-1BBD-484B-BD44-5C6BFA19F404Q26775809-99AD01C8-63BA-49AA-A390-6B6C660B6BB2Q27490161-1D7FB6CA-1747-4124-83D6-AFE5C9E7BC47Q28085718-0790BEE7-1181-4473-9409-54146F844577Q28727978-16DB1C2C-D79D-43FB-9FC6-B8F530AFA284Q29619682-E2B3E593-3036-4885-B8CB-C45AB4EDA358Q30402571-4558CC05-9175-4500-B942-8681EB1525AEQ30417970-6CA3407D-66FA-47C2-B4BE-4308C612082FQ33195269-204E6D47-CC8F-4F43-8541-CA69EE2F3271Q33632731-9B524AE4-D27B-42B9-8C0B-06C24A82B10CQ33759637-8004D4FC-1E9F-48B2-A451-85DB294C577DQ33867045-0E4E9CF5-3FE7-48F6-99FB-3958C3107D9BQ33972205-C6D2CDCD-7250-4816-A2B4-D3993B3D613DQ34013192-7C51E5CC-E92C-424C-9DD1-CF21D6392D16Q34321014-17C8D77E-FAA8-43C0-B20A-8F827CA9A80FQ34415344-65AA016B-4FF1-4C22-8449-6EFA4B616EFEQ34581499-F4E6C1B0-E72F-4675-B6A5-E97E7784E417Q34678366-CCC2BEA3-51F8-4980-8D85-78F7029B7973Q34747549-419584F2-99F9-4C4B-97B9-85354A91F0A3Q34984040-E51E7584-F8E0-461D-905B-A4AE1D8FA5F2Q35098353-AA47AF7B-11F2-4322-8A2A-92E767634B35Q35598407-F9430F75-06B6-404E-B3B2-E50296AC78D9Q36168072-4A3715B1-B8F0-4054-B47C-94D5C690ED42Q36336416-E2868DF0-3DD9-4E1E-8587-BADF65DD1B80Q36523107-74C9FBED-D6E6-437A-B7E7-126D833F27C1Q36566758-FB8C9C03-120C-4FF0-A194-DC7B94BF4BA0Q36609890-56621E34-E666-408C-8107-34A2B101AAF9Q36717008-CD15941B-B7C7-49BB-AE8F-90A48A1E4927Q36720968-157C16A8-B816-4861-B540-A2F39EFB70DFQ37055955-0D208EDD-5FC3-41DE-84DB-93701666958BQ37066392-787B0DEB-709D-41B9-8474-C9590FE33EDBQ37180035-CD6DC7FC-771F-4556-9F64-3BE83DBE25C5Q37199380-F629A060-9585-41C3-8D4B-5A28FA794907Q37225844-E1DDE207-0126-4BC1-BABD-ADD4DA50B46CQ37354282-4E08C5BD-CCE8-42F0-8FC8-D96B8CDB9CAFQ37504457-5CFA2AB7-9F8A-4FA8-82A5-0D5B6E75F330Q37781667-EFFCB2B7-42DC-423D-99EC-9663A65BC47FQ37855530-F5B2F715-EB28-41F7-B4C2-6EC2ECC61C43
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hepatitis C: the clinical spectrum of the disease.
@ast
Hepatitis C: the clinical spectrum of the disease.
@en
type
label
Hepatitis C: the clinical spectrum of the disease.
@ast
Hepatitis C: the clinical spectrum of the disease.
@en
prefLabel
Hepatitis C: the clinical spectrum of the disease.
@ast
Hepatitis C: the clinical spectrum of the disease.
@en
P1476
Hepatitis C: the clinical spectrum of the disease.
@en
P2093
Marcellin P
P356
10.1016/S0168-8278(99)80368-7
P478
31 Suppl 1
P577
1999-01-01T00:00:00Z